Xiaohua Xue

1.2k citations
26 papers · 705 indexed · h-index 15
Topics
Asthma and respiratory diseases (8 papers)Psoriasis: Treatment and Pathogenesis (7 papers)IL-33, ST2, and ILC Pathways (5 papers)
Partner nations
United StatesCanadaChina

In The Last Decade

Xiaohua Xue

24 papers receiving 683 citations

Peers

Xiaohua Xue
Comparison fields: 5 of 103
  • Molecular Biology 227
  • Immunology 223
  • Physiology 129
  • Ecology 96
  • Oncology 83
Replace Sandra M. Jones with:
Sandra M. Jones United States
Munehisa Yabuki Japan
Laxmikanth Kollipara Germany
Ritu Sharma United Kingdom
Osamu Suzuki Japan
Gerard C.M. van der Zon Netherlands
Franco Dallocchio Italy
Lindsay K. Pino United States
Mizuho Kaneda Japan
Manfred Alexander United States
Xiaohua Xue relative to Sandra M. Jones United States Sandra M. Jones's profile →
Citations per field
00.5×
Sandra M. Jones · 1×
Citations per year

Countries citing papers authored by Xiaohua Xue

Since Specialization
Citations

This map shows the geographic impact of Xiaohua Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohua Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohua Xue more than expected).

Fields of papers citing papers by Xiaohua Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohua Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohua Xue. The network helps show where Xiaohua Xue may publish in the future.

Co-authorship network of co-authors of Xiaohua Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohua Xue. A scholar is included among the top collaborators of Xiaohua Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohua Xue. Xiaohua Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 28
5 14
6 10
7 9
8 110
9 53
10 19
11 12
12 52
13 47
14 78
15 33
16 2
17 13
18 35
19 39
20 20

About Xiaohua Xue

Xiaohua Xue is a scholar working on Aging, Immunology and Immunology and Allergy, having authored 26 papers that have together received 705 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (8 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and IL-33, ST2, and ILC Pathways (5 papers). The work is most often cited by research in Immunology (223 citations), Biochemistry (41 citations) and Physiology (129 citations). Xiaohua Xue has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Anne M. Fourie, Glen F. Tibbits, Christian R. Marshall, Lars Karlsson, Larry V. Hryshko, Jason P. Riley, Katherine A. Lundeen, Paul J. Dunford, James P. Edwards and Glenda Castro. Their work appears in journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026